NASDAQFinancialsInsurance - BrokersSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for EZRA yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Manage capital structure with disciplined debt and equity | A supporting condition in RELIANCE GLOBAL GROUP INC's published investment case. The stated target is Maintain capital access with promissory note up to $2M in 2026-Q1. | Intact | Failure to maintain or access capital via promissory note by 2026-Q1 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 7–Nov 5 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative turnaround, meaning the case depends on improving a weak business rather than steady growth. The thesis is on watch: the signal recently shifted from cautious to mixed, but recent performance remains well below its industry cohort.
EZRA is described as cheap versus peers, with a low-confidence valuation model and a negative expectations gap. The priced-in assessment is justified and fragility is low, but these labels do not remove the uncertainty created by losses and volatile management.
Near term, results face elevated risk of a miss because recent earnings surprises have been erratic. In 2026-Q2, revenue fell year over year, mainly due to divestitures, and operating income remained negative despite a reported 28% reduction in operating expenses. AI deployment and portfolio changes are stated priorities, but evidence of measured benefits is limited so far.
The multi-year case hinges on whether retained businesses can grow enough to offset divestitures, while cost discipline improves operating performance and the AI platform produces measurable results. Near term, a guidance cut would be a negative; continued strength from sector bellwethers could support sector momentum, while rate cuts may weigh on Financials names.
Over the next 1 to 3 years, EZRA remains a high-risk turnaround with early signs of restructuring but no demonstrated return to profitability. The thesis depends on execution improving results, while near-term earnings risk remains elevated. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in a supplied disclosure. Management reported: “Reliance reiterated that it is debt-free, having retired 100% of its term debt.” “The proposed acquisition is structured to result in no dilution to existing shareholders, as the purchase price is payable entirely in cash and no shares of the Company’s common stock will be issued as consideration for the acquisition, and the funds required to complete the transaction are already in place.”
Strengthen executive leadership team | A supporting condition in RELIANCE GLOBAL GROUP INC's published investment case. The stated target is Sustain stable leadership with key executive roles filled in 2026-Q2. | Intact | Leadership instability or key executive departures in 2026-Q2 | Qualitative condition This condition has no defined numerical measure. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Complete acquisitions and grow revenue through M&A | Reliance Global Group grows through acquisitions, completing multiple deals by 2026-Q1. | Improving | Failure to complete multiple acquisitions by 2026-Q1 | 1 acquisition completed vs multiple required Company completed the Altruis acquisition in September 2026, advancing the M&A objective, though multiple deals are still required to meet the target. Nov 5, 2026Last status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Improve operating cash flow to reduce negative cash burn | A primary condition in RELIANCE GLOBAL GROUP INC's published investment case. The stated target is Operating cash flow improves to positive or near zero next 4 quarters. | Broken | Operating cash flow remains negative below -$1.6M next 4 quarters | Cash from operations: $-1.66M FY2026-Q2; GAAP. Published target: Operating cash flow improves to positive or near zero next 4 quarters. Target period is not explicitly aligned with this observation. Jul 30, 2026-1,660,379 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.